You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 28, 2025

Details for Patent: 11,192,897


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,192,897 protect, and when does it expire?

Patent 11,192,897 protects ICLUSIG and is included in one NDA.

This patent has thirty-four patent family members in nine countries.

Summary for Patent: 11,192,897
Title:Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt
Abstract: Novel crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide free base and 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, pharmaceutical compositions thereof and methods of their preparation and use are disclosed herein.
Inventor(s): Murray; Christopher K. (Lexington, MA), Rozamus; Leonard W. (Andover, MA), Chaber; John J. (Westford, MA), Sharma; Pradeep K. (Westford, MA)
Assignee: ARIAD PHARMACEUTICALS, INC. (Cambridge, MA)
Application Number:17/318,832
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 11,192,897
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,192,897

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. Here, we will delve into the details of United States Patent 11,192,897, focusing on its scope, claims, and the broader patent landscape.

Understanding Patent Scope

The scope of a patent is defined by its claims, which outline the specific invention and its boundaries. The scope is a critical aspect of patent quality, as it affects the patent's novelty, clarity, and validity[3][4].

Patent Claims

Patent claims are the heart of any patent application. They define what the inventor considers to be the invention and are used to determine the scope of the patent.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are typically broader and more comprehensive.
  • Dependent Claims: These claims refer back to and further limit an independent claim. They are narrower and often provide additional details or specific embodiments of the invention[3].

For United States Patent 11,192,897, it is essential to analyze both the independent and dependent claims to understand the full scope of the invention.

Claim Language and Clarity

The clarity of claim language is a significant factor in patent quality. Clear and concise claims help in avoiding ambiguity and ensure that the patent is enforceable. The USPTO has emphasized the importance of clear claim language, suggesting tools like glossaries of key terms and claim charts to improve clarity[4].

Patent Examination Process

The examination process plays a crucial role in shaping the scope of a patent. During this process, the claims may be narrowed or broadened based on the interactions between the patent examiner and the applicant. Research has shown that the examination process tends to narrow the scope of patent claims, particularly in terms of claim length and count, leading to a higher probability of grant and a shorter examination process[3].

Global Dossier and International Patent Landscape

To fully understand the scope and claims of a patent, it is important to consider the global patent landscape. Tools like the Global Dossier provided by the USPTO allow users to view the patent family for a specific application, including related applications filed at participating IP Offices. This helps in identifying potential overlaps or conflicts with other patents worldwide[1].

Searching Published Sequences and Assignments

For patents involving sequences or other complex data, resources like the Publication Site for Issued and Published Sequences (PSIPS) and the Patent Assignment Search website are invaluable. These tools help in verifying the ownership and specific details of the patent, ensuring that all relevant information is considered when analyzing the scope and claims[1].

Public Search Facilities and PTRCs

Utilizing public search facilities and Patent and Trademark Resource Centers (PTRCs) can provide additional resources and expertise. These centers offer training in patent search techniques and access to local search resources, which can be particularly useful for detailed analyses of patent scope and claims[1].

Case Law and Litigation

Court cases involving patent disputes can provide insights into how the scope and claims of a patent are interpreted. For example, in cases like TAKEDA PHARMACEUTICALS AMERICA, INC. et al v. APOTEX, INC., the court's opinion on the meaning of the claims can set precedents and influence future interpretations of similar patents[5].

Key Metrics for Measuring Patent Scope

Research has identified metrics such as independent claim length and independent claim count as useful for measuring patent scope. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Best Practices for Patent Search

Conducting a thorough patent search involves several steps:

  • Preliminary Search: Use tools like the Patent Public Search to identify existing patents and published patent applications.
  • Global Search: Utilize databases from international intellectual property offices to ensure the idea has not been patented abroad.
  • Public Search Facilities: Leverage resources at the USPTO Public Search Facility and PTRCs for expert assistance.
  • Sequence and Assignment Searches: Verify specific details using PSIPS and the Patent Assignment Search website[1].

Conclusion

Analyzing the scope and claims of United States Patent 11,192,897 requires a comprehensive approach that includes understanding the claim language, the examination process, and the global patent landscape. By utilizing various resources and tools provided by the USPTO and other international intellectual property offices, one can gain a detailed insight into the patent's validity and potential impact.

Key Takeaways

  • Clear Claim Language: Ensuring clarity in claim language is crucial for patent quality and enforceability.
  • Global Patent Landscape: Considering the global patent landscape helps in identifying potential overlaps or conflicts.
  • Examination Process: The examination process can significantly narrow or broaden the scope of patent claims.
  • Public Search Facilities: Utilizing public search facilities and PTRCs can provide valuable resources and expertise.
  • Metrics for Patent Scope: Independent claim length and count are useful metrics for measuring patent scope.

FAQs

Q: What is the importance of clear claim language in a patent? A: Clear claim language is essential for avoiding ambiguity and ensuring the patent is enforceable. It helps in defining the invention precisely and reduces the risk of litigation.

Q: How does the Global Dossier help in patent analysis? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and identify potential global conflicts.

Q: What are the key metrics for measuring patent scope? A: Independent claim length and independent claim count are commonly used metrics for measuring patent scope, as they have explanatory power for several correlates of patent scope.

Q: Why is it important to consider the global patent landscape? A: Considering the global patent landscape helps in identifying potential overlaps or conflicts with other patents worldwide, ensuring that the patent does not infringe on existing patents in other countries.

Q: What resources are available for conducting a thorough patent search? A: Resources include the Patent Public Search, Global Dossier, Public Search Facilities, PTRCs, and international intellectual property office databases.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,192,897

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Takeda Pharms Usa ICLUSIG ponatinib hydrochloride TABLET;ORAL 203469-004 Dec 18, 2020 RX Yes No ⤷  Try for Free ⤷  Try for Free Y A METHOD FOR TREATING PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ⤷  Try for Free
Takeda Pharms Usa ICLUSIG ponatinib hydrochloride TABLET;ORAL 203469-004 Dec 18, 2020 RX Yes No ⤷  Try for Free ⤷  Try for Free Y A METHOD FOR TREATING LEUKEMIA RESULTING FROM A MUTATION IN THE BCR-ABL KINASE DOMAIN ⤷  Try for Free
Takeda Pharms Usa ICLUSIG ponatinib hydrochloride TABLET;ORAL 203469-004 Dec 18, 2020 RX Yes No ⤷  Try for Free ⤷  Try for Free Y A METHOD FOR TREATING CHRONIC MYELOID LEUKEMIA ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 3 of 3 entries

International Family Members for US Patent 11,192,897

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2013204506 ⤷  Try for Free
Australia 2016210725 ⤷  Try for Free
Australia 2018201013 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.